Words matter: a randomized controlled study evaluating the impact of decision‐framing on treatment preferences in adults with psoriasis and psoriatic arthritis

Kassardjian, A.; Chat, Vipawee S; Archuleta, L.; Hekmatjah, Joshua; Sierro, Tiffany; Read, Charlotte; Chen, A.Y.; Singh, Inderpreet; Armstrong, April W.

doi:10.1111/bjd.19746

Cited by 2 publications

(4 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Loss‐framing, which emphasised the harmful effects of not treating skin and joint diseases, was more effective in influencing patient preferences than gain‐framing. This effect was consistent regardless of the presence of psoriatic arthritis or patients' sex 19 . In light of these findings, utilising loss‐framing may prove effective in addressing steroid phobia among patients.…”

Section: A Behaviour Economics Approach To Addressing Steroid Phobiasupporting

confidence: 56%

“…This effect was consistent regardless of the presence of psoriatic arthritis or patients' sex. 19 In light of these findings, utilising lossframing may prove effective in addressing steroid phobia among patients. By emphasising the potential exacerbation of skin rashes without topical steroids and the associated risks of sepsis and other complications, this approach may facilitate a better understanding of the importance of topical steroid treatment.…”

Section: A Behaviour Economics Approach To Addressing Steroid Phobiamentioning

confidence: 99%

See 1 more Smart Citation

Tackling steroid phobia: Insights from behavioural economics and psychological approaches

Nakashima,

Ohtake,

Otsuka

2023

JEADV Clinical Practice

View full text Add to dashboard Cite

Steroid phobia, characterized by an irrational fear or avoidance of topical corticosteroids, poses a significant challenge to the effective treatment of various skin conditions, including atopic dermatitis (AD) and psoriasis. This issue has its roots in the introduction of topical corticosteroids in the 1950s and has been perpetuated by concerns regarding adverse effects and misinformation. International Dermatological Societies including the Japanese Dermatological Association have endeavored to address this problem by providing information and guidance to physicians and patients, resulting in a better understanding of appropriate steroid use and risk management. Despite these efforts, steroid phobia has not been fully resolved in the world, including in Japan. To shed light on potential solutions, this review explores the field of behavioral economics, which offers insights into human decision-making processes and cognitive biases. Richard Thaler's concept of nudges emerges as a promising strategy for influencing patients' decision-making regarding steroid treatments. However, the effectiveness of nudges may vary depending on the strength of an individual's concerns and fears. In cases where patients exhibit strong resistance to steroid use, alternative psychological techniques that establish trust and facilitate clear communication may be more beneficial. This review emphasizes the necessity of adopting a multifaceted approach that integrates principles from behavioral economics and employs complementary psychological strategies to address steroid phobia and enhance treatment adherence in affected patient populations. By combining these approaches, healthcare professionals can tackle the complex nature of steroid phobia and promote better treatment outcomes for patients with skin conditions.

show abstract

Section: A Behaviour Economics Approach To Addressing Steroid Phobiasupporting

confidence: 56%

Section: A Behaviour Economics Approach To Addressing Steroid Phobiamentioning

confidence: 99%

Tackling steroid phobia: Insights from behavioural economics and psychological approaches

Nakashima,

Ohtake,

Otsuka

2023

JEADV Clinical Practice

View full text Add to dashboard Cite

show abstract

“…7 The effect of positive framing, another mathematically accurate way to communicate risk, may alleviate excessive fears and promote increased acceptance of and adherence to treatment. 7,8 There are practical considerations to utilizing tildrakizumab, including convenience, cost-effectiveness and coverage. 9 Tildrakizumab is approved only for healthcare providers' administration and is dosed on 12-week intervals, 10 which may coincide nicely with return visit intervals, is likely to improve patient adherence, and mightdepending on the health systembe more accessible to patients.…”

mentioning

confidence: 99%

“…Instead, communicating serious adverse event frequency with positive framing may reassure patients of the equivalent: 99 out of 100 patients receiving tildrakizumab do not experience a serious infection (per year) 7 . The effect of positive framing, another mathematically accurate way to communicate risk, may alleviate excessive fears and promote increased acceptance of and adherence to treatment 7,8 …”

mentioning

confidence: 99%